Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08IYF
|
|||
| Former ID |
DIB000520
|
|||
| Drug Name |
GSK-692342
|
|||
| Synonyms |
GSK-M72; M-72; MTB72F vaccine (tuberculosis); Mtb72F/AS02A; Tuberculosis vaccine, GlaxoSmithKline; Mtb antigens, Corixa/GlaxoSmithKline; TB vaccine, Corixa/GlaxoSmithKline; Tuberculosis vaccine, Corixa/GlaxoSmithKline; Tuberculosis vaccine, Corixa/SB; MTB72F vaccine (tuberculosis), GSK/Aeras;Mtb8.4, Corixa/GlaxoSmithKline; Vaccine (tuberculosis), Corixa/GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Influenza A virus H1N1 infection [ICD-11: 1E30] | Phase 2 | [1] | |
| Company |
Glaxosmithkline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024374) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.